Security record · archived quarter
VHT
Vanguard Health Care ETF · Financial Services · Asset Management
4Tracked holders
-2Δ holders
37.35KShares held
$9.89MReported value
+0New positions
−2Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | +1 | 11.43M | $3.42B | +7 | −6 |
| Q1 2026 | 77 | -3 | 11.40M | $3.10B | +3 | −6 |
| Q4 2025 | 80 | +2 | 11.59M | $3.33B | +3 | −1 |
| Q3 2025 | 10 | -1 | 2.06M | $533.75M | +1 | −2 |
| Q2 2025 | 8 | +1 | 112.24K | $27.87M | +1 | — |
| Q1 2025 | 4 | -2 | 37.35K | $9.89M | — | −2 |
| Q4 2024 | 6 | -2 | 170.72K | $43.31M | — | −2 |
| Q3 2024 | 8 | +4 | 63.69K | $17.97M | +4 | — |
| Q2 2024 | 4 | — | 46.06K | $12.25M | — | — |
Who holds it · Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 20.16K | +35.6% | $5.34M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | Two Sigma Investments ✦ | 11.00K | -90.7% | $2.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 3.94K | +7.7% | $1.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Fisher Asset Management ✦ | 2.25K | +108.2% | $596,642 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| D. E. Shaw & Co. | $7.84M | was 0.0% |
| Renaissance Technologies | $634,225 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,076 holders, 20.92M shares, $5.29B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q1 2025 ·
Methodology ·
Get this via the API